The Effectiveness of Intravitreal Avastin Injection for CRVO

Ziv Hospital68 enrolled

Overview

to determine the effectivness of intravitreal avastin injection on visual acuity on people that suffer from central retinal vein occlusion

Study Type

OBSERVATIONAL

Enrollment

Conditions

Central Retinal Vein Occlusion

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * patients above 18 years old * suffer from CRVO * maximal visual acuity 6/15 Exclusion Criteria: * VA of LP * retinal disease other than CRVO * incomplete medical record * follow up less than 6 months

Locations (1)

Ziv Medical Center

Safed, Israel

RECRUITING

Central Contacts

Joseph pikkel, M.D

CONTACT

972508434206 pikel.y@ziv.health.gov.il

Otzem Chassid, M.D

CONTACT

972506266059 otzem.c@ziv.health.gov.il

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.